Pfizer Inc
Pfizer RSV vaccine for infants has ‘generally favorable’ safety data, FDA staff say
Blood sample for respiratory syncytial virus (RSV) test Jarun011 | Istock | Getty Images U.S. Food and Drug Administration staff on Tuesday said Pfizer’s vaccine that protects infants from respiratory syncytial virus has “generally favorable” safety data. The FDA staff made the conclusion in briefing documents ahead of a meeting on Thursday, when a panel […]
Read More
Google Cloud launches A.I.-driven resources to accelerate drug discovery, precision medication
A particular person walks upcoming to the Google Cloud symbol at the Mobile Globe Congress (MWC) in Barcelona, Spain February 27, 2023. Nacho Doce | Reuters Google Cloud on Tuesday introduced two new AI-run instruments that intention to help biotech and pharmaceutical companies speed up drug discovery and progress precision medication. One resource, identified as […]
Read More
Universal flu vaccine based on mRNA tech to be tested by National Institutes of Health
A woman receives a booster dose of the Moderna coronavirus disease (COVID-19) vaccine at a vaccination centre in Antwerp, Belgium, February 1, 2022. Johanna Geron | Reuters Patients are now enrolling in an early stage clinical trial to test a universal flu vaccine based on messenger RNA technology, the National Institutes of Health announced Monday. […]
Read More
Here’s why Covid vaccines will still be free for uninsured Americans as public health emergency ends
A healthcare worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images Uninsured Americans can still access Covid-19 vaccines at no cost, for now, even though the U.S. public health emergency has […]
Read More
Pfizer CEO says Medicare will likely face legal action over drug price negotiations
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021. John Thys | AFP | Getty Images Pfizer CEO Albert Bourla on Thursday said pharmaceutical companies […]
Read More
Novavax shares rise after company unveils positive vaccine data, plan to cut 25% of workforce
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Shares of Novavax rose 5% in premarket trading Tuesday after the company unveiled promising new vaccine data and a […]
Read More
Moderna posts surprise quarterly profit despite waning demand for Covid vaccines
Moderna’s sign is seen outside of their headquarters in Cambridge, MA on March 11, 2021. Boston Globe | Getty Images Moderna on Thursday blew past estimates for first-quarter earnings and revenue, posting a surprise quarterly profit, despite lower demand for Covid vaccines, its only marketable product. The biotech company generated first-quarter sales of $1.9 billion, […]
Read More
FDA approves GSK’s RSV vaccine for older adults, world’s first shot against virus
A GSK lab in London. Oli Scarff | Getty Images The Food and Drug Administration on Wednesday approved an RSV vaccine produced by GlaxoSmithKline for use on adults ages 60 and older. The approval, the first ever globally by a regulatory body for an RSV vaccine, is a decisive victory for GSK in a race […]
Read More
Shares generating the largest premarket moves: Uber, Pfizer, Chegg, Dell & far more
In this article CHGG MAR UBER PFE BP.-GB Abide by your preferred sharesCreate Absolutely free ACCOUNT Travelers wait for an Uber rideshare motor vehicle at Los Angeles Global Airport (LAX) on February 8, 2023 in Los Angeles, California. Mario Tama | Getty Photographs Test out the providers making the largest moves in premarket buying and […]
Read More
Pfizer earnings and revenue top expectations despite Covid vaccine sales decline
Pharmaceutical Pfizer Inc. said that an oral drug for treating COVID-19 could be available by end of 2021. Soumyabrata Roy | NurPhoto | Getty Images Pfizer on Tuesday reported first-quarter revenue and adjusted earnings that topped Wall Street’s expectations, despite a decline in sales driven by the lower demand for the company’s Covid vaccine. Pfizer’s […]
Read More